RENOVARO INC. - COMMON STOCK

Renovaro Appoints Nathen Fuentes as Chief Financial Officer

07 1 2025 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

07 1 2025 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro to Acquire Predictive Oncology in All-Stock Transaction

06 1 2025 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV

30 12 2024 09:00:05 提供 Nasdaq GlobeNewswire

RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program

23 12 2024 09:00:00 提供 Nasdaq GlobeNewswire

Renovaro Regains Compliance with NASDAQ Listing Requirement

20 12 2024 15:40:00 提供 Nasdaq GlobeNewswire

Renovaro Enters into a Strategic Collaboration with Nebul to Advance a Paradigm Shift for Early Disease Detection

20 12 2024 09:00:00 提供 Nasdaq GlobeNewswire

Renovaro Issues Shareholder Letter and Provides Corporate Update

04 11 2024 08:31:00 提供 Nasdaq GlobeNewswire

RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing

17 10 2024 09:15:17 提供 Nasdaq GlobeNewswire

Renovaro Announces Strategic Restructuring and Leadership Transition

16 10 2024 09:28:06 提供 Nasdaq GlobeNewswire

PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics

19 9 2024 09:00:00 提供 Nasdaq GlobeNewswire

Independent Expert Assessment Validates RenovaroCube’s Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection

17 9 2024 09:00:00 提供 Nasdaq GlobeNewswire

RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress

13 9 2024 09:00:00 提供 Nasdaq GlobeNewswire

RenovaroCube Announces Strategic Offering of Up to 20% Ownership

11 9 2024 09:15:00 提供 Nasdaq GlobeNewswire

Renovaro, Inc. Announces $10 million in Equity Committed

14 6 2024 09:06:00 提供 Nasdaq GlobeNewswire

Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy

24 5 2024 09:20:00 提供 Nasdaq GlobeNewswire

Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics

30 4 2024 11:00:00 提供 Nasdaq GlobeNewswire

RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership

24 4 2024 09:00:00 提供 Nasdaq GlobeNewswire

Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care

18 4 2024 08:45:00 提供 Nasdaq GlobeNewswire

Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace

15 2 2024 09:25:00 提供 Nasdaq GlobeNewswire